Issue 3/2015
Content (12 Articles)
Immunotherapies and novel combinations: the focus of advances in the treatment of melanoma
Paolo A. Ascierto
Expression and function of Toll-like receptors in peripheral blood mononuclear cells from patients with ovarian cancer
Xiaojie Zhang, Juan Xu, Xing Ke, Shuping Zhang, Peijun Huang, Ting Xu, Lei Huang, Jianfang Lou, Xinhui Shi, Ruihong Sun, Fang Wang, Shiyang Pan
Development of photodynamic therapy regimens that control primary tumor growth and inhibit secondary disease
Madeeha Shams, Barbara Owczarczak, Patricia Manderscheid-Kern, David A. Bellnier, Sandra O. Gollnick
Glioblastoma exosomes and IGF-1R/AS-ODN are immunogenic stimuli in a translational research immunotherapy paradigm
Larry A. Harshyne, Kirsten M. Hooper, Edward G. Andrews, Brian J. Nasca, Lawrence C. Kenyon, David W. Andrews, D. Craig Hooper
Blockade of CTLA-4 promotes the development of effector CD8+ T lymphocytes and the therapeutic effect of vaccination with an attenuated protozoan expressing NY-ESO-1
Luara Isabela dos Santos, Bruno Galvão-Filho, Paula Cristina de Faria, Caroline Junqueira, Miriam Santos Dutra, Santuza Maria Ribeiro Teixeira, Maurício Martins Rodrigues, Gerd Ritter, Oliver Bannard, Douglas Thomas Fearon, Lis Ribeiro Antonelli, Ricardo Tostes Gazzinelli
Protection from tumor recurrence following adoptive immunotherapy varies with host conditioning regimen despite initial regression of autochthonous murine brain tumors
Eugene M. Cozza, Timothy K. Cooper, Lynn R. Budgeon, Neil D. Christensen, Todd D. Schell
Activated regulatory and memory T-cells accumulate in malignant ascites from ovarian carcinoma patients
Johannes Landskron, Øystein Helland, Knut Martin Torgersen, Einar Martin Aandahl, Bjørn Tore Gjertsen, Line Bjørge, Kjetil Taskén
Fever and the use of paracetamol during IL-2-based immunotherapy in metastatic melanoma
Anne Helene Køstner, Mai-Britt Bjørklund Ellegaard, Ib Jarle Christensen, Lars Bastholt, Henrik Schmidt
Association of high CD4-positive T cell infiltration with mutations in HLA class II-regulatory genes in microsatellite-unstable colorectal cancer
Eva-Maria Surmann, Anita Y. Voigt, Sara Michel, Kathrin Bauer, Miriam Reuschenbach, Soldano Ferrone, Magnus von Knebel Doeberitz, Matthias Kloor
A phase I dose escalation trial of MAGE-A3- and HPV16-specific peptide immunomodulatory vaccines in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN)
Dan P. Zandberg, Sandra Rollins, Olga Goloubeva, Robert E. Morales, Ming Tan, Rodney Taylor, Jeffrey S. Wolf, Lisa M. Schumaker, Kevin J. Cullen, Ann Zimrin, Robert Ord, Joshua E. Lubek, Mohan Suntharalingam, John C. Papadimitriou, Dean Mann, Scott E. Strome, Martin J. Edelman
Long-term clinical outcome of melanoma patients treated with messenger RNA-electroporated dendritic cell therapy following complete resection of metastases
Sofie Wilgenhof, Jurgen Corthals, An M. T. Van Nuffel, Daphné Benteyn, Carlo Heirman, Aude Bonehill, Kris Thielemans, Bart Neyns
Tumor-induced CD14+HLA-DR−/low myeloid-derived suppressor cells correlate with tumor progression and outcome of therapy in multiple myeloma patients
Zhitao Wang, Lulu Zhang, Huiping Wang, Shudao Xiong, Yanli Li, Qianshan Tao, Weihua Xiao, Hui Qin, Yiping Wang, Zhimin Zhai